Home MarketMarksans Pharma Ltd.

Marksans Pharma Ltd. Stock Info: As on 2018-05-24 15:59:58

Nse

29.00

0.40(1.40%)
Change%
52 Week Range
25.30
14.00
52.30
6.00
Open29.00
Day's Range22.88 - 34.32
Value Traded (in ₹ Cr.) 6.18

Bse

29.00

0.40(1.40%)
Change %
52 Week Range
25.25
14.00
52.25
6.00
Open29.25
Day's Range22.88 - 34.32
Value Traded (in ₹ Cr.) 0.96

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 197,491,733.00 48.25%
Mutual Funds/UTI 0.00 0.00%
FII 12,942,237.00 3.16%
Employee 0.00 0.00%
Public 159,213,146.00 38.90%
Government 0.00 0.00%
Others 32,543,370.00 7.95%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 8.94
Basic EPS (Rs.) 0.30
Cash EPS 0.66
BVPerShare Excl 10.24
Operating Revenue 5.27
PBDITPerShare 0.75
Dividend 0.05
NPPerShare 0.29
Current Ratio 1.88
Quick Ratio 1.63
PriceToBV 4.61
Earnings 0.01
PBDIT Margin 14.37
PBT Margin 5.82
NP Margin 5.66
Return On Assets 2.23
Retention Ratios 76.96
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 222.67
Total Expenses 210.10
EBITDA 31.02
PBT 12.58
PAT 12.23
Net Income 12.23
More
Parameter Sep-17 (₹ Cr.) 6M % change
Total Income 127.84
Total Expenses 120.72
EBITDA 0.01
PBT 3.30
PAT 2.48
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 51.93
Net worth 441.03
Investments 234.29
Total Liability 545.96
Total debt 62.23
Net block 94.28
Total Assets 545.96
Parameter Sep-17 (₹ Cr.) 6M % change
Total share capital 53.43
Net worth 410.59
Investments 222.34
Total Liability 548.53
Total debt 42.56
Net block 97.62
Total Assets 548.53
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

533.05 531.95 0.21
524.95580

Abbott India Ltd.

6671.7 6587.45 1.28
65106890

Ajanta Pharma Ltd.

977.6 987 -0.95
962.351074.5

Albert David Ltd.

362.35 362.75 -0.11
356.2383.15

Alembic Ltd.

48.85 50.8 -3.84
50.254

Alembic Pharmaceuticals Ltd.

420.7 422.3 -0.38
418.5491.2

Alkem Laboratories Ltd.

1957.55 1965.35 -0.4
18882036.65
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

47.5 49.05 -3.16
46.351.55

Aarti Drugs Ltd.

530 529.15 0.16
526585

Aayush Food & Herbs Ltd.

47.7 48.1 -0.83
4355

Abbott India Ltd.

6699.95 6593.7 1.61
6465.056872.5

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities -18.67
Cash from investing activities -7.80
Cash from financing activities 25.90
Net change in cash -0.57

Stock Held By Mutual Fund Schemes

Corporate Details

About Management

TASC Industries (India) Ltd. was incorporated on 16th April 1992 as a Public Limited Company under the Companies Act 1956 at Bombay in the state of Maharshtra. The certificate of commencement of business was obtained on 5th June 1992. The company has been promoted by Mr. Vijay Thakkar, Mr. Sanjay Thakkar and Mr. Sanjay Sahu to set up a plant for manufacture of Ciprofloxacin, Chloramphenicol and Chloramphenicol Palmoate. The promoterws have been trading in bulk drugs and formulations for the past eight years through their associate concern Tasc Chemical India Pvt. Ltd. 2005 -Company has changed its name from Tasc Pharmaceuticals Ltd. to Marksans Pharma Ltd. 2006 - Marksans Pharma Ltd has informed that the Board of Directors of the Company at its meeting held on October 30, 2006 has appointed Mr V Nagaraj as Additional as well as Whole Time Director (marketing) of the Company. -Marksans Pharma Limited has appoineted Mr. V. Nagaraj as Additional as well as Whole Time Director (marketing) of the Company. 2008 - The Company has splits its face value from Rs10/- to Rs1/-. -Registered Office of the Company has been shifted From 601-622, Chintamani Plaza, Mohan Studio Compound, Andheri-Kurla Road, Andheri (E), Mumbai 400 099 To 21st Floor, Lotus Business Park, Off New Link Road, Andheri (W), Mumbai 400 0530. 2009 -"Marksans Pharma Limited announces USFDA approval of generic Ibuprofen Capsules (Liquid Filled), 200 mg for Advil Liqui - Gels 200 mg." 2010 -Company has entered into a Business Transfer Agreement with Kores (India) Limited -Registered Office of the Company has been shifted From 21st Floor, Lotus Business park, Off New Link Road, Andheri (W), Mumbai - 400053 To 11th Floor, Lotus Business Park, Off New Link Road, Andheri (W), Mumbai - 400053. 2011 -Dr. Balwant Shankarrao Desai has been appointed as a Whole-time Director of the Company 2012 - Mr. Ajay S. Joshi has been appointed as a Director of the Company 2013 -Marksans Pharma Ltd has appointed Mr. Naresh Balwant Wadhwa as an additional Director of the Company. Mr. Wadhwa will be an independent non-executive director. 2014 -Marksans Pharma Ltd has recommended dividend of 10% which is Rs. 0.10 per equity share of Rs. 1/- each face value. -The Registered office of the company has been shifted from old location to 11th Floor, "GRANDEUR", Opp. Gundeecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai -400053, Telephone: +91 22 4001 2000,Telefax: +91 224001 2011, E-mail: companysecretary@marksanspharma.com 2015 -Marksans Pharma gains on acquiring Time-Cap Laboratories 2016 -Marksans Pharma gets USFDA nod for Paricalcitol capsules -Marksans Pharma gets USFDA nod for diabetes treatment drug -Marksans Pharma bags USFDA approval for Loratadine

Registered Office

Formulation Plant: Time-Cap Laboratories Inc., 7, Michael Avenue, Farmingdale,

,,,      ,

Registrar Details

Bigshare Services Pvt. Ltd.